Cardio Renal Metabolic Conference – West Midlands

West Midlands Cardio Renal Metabolic Conference with a focus on Heart failure and CKD

3 Hour Face to Face Educational Event will:

• Address the specific needs of primary and community care clinicians: GPs, GPSIs, clinical pharmacists, practice nurses, diabetes specialist nurses, and cardiac nurses.
• Include a focus on improving cardiovascular outcomes in Type 2 diabetes, early identification of heart failure and modern management of HFrEF and CKD (with a predominant focus on CKD).
• Discussion of new evidence, guidance and licenced indications.
• Case based assessments to consolidate learning for attendees.
• Event handout and certificate for accredited CPD points for all attendees following the event.

Who should attend:

• Partner and Salaried GPs
• GPwSIs in Diabetes and Cardiology
• Prescribing Clinical Pharmacists
• Practice Nurse Prescribers
• HF Nurses: Community and Hospital
• Diabetes Specialist Nurses

How will this conference benefit patients?

The upskilling of HCPs in primary care in the modern management of Type 2 diabetes, heart failure and CKD and reinforcement of recent evidence, guidance and licenced indications will aim to address the unmet need by:

• Improving the management of cardiovascular risk factors in patients with Type 2 Diabetes and a move away from glucose-centricity
• Increasing the uptake of therapies such as SGLT2is with proven cardiovascular benefit early in the management of Type 2 Diabetes and CKD (with or without diabetes)
• Increasing detection of heart failure and crucially facilitating earlier detection by identifying high-risk cohorts to screen
• Earlier detection and optimised management of CKD
• Encourage appropriate de-prescribing of sulphonylureas and DPP4is

Speaker: Dr Yassir Javaid, GPwSI Cardiology Northampton

Chair: Dr Kamran Ahmed, Clinical Lead Unity PCN, Board Member Black Country ICB

Note:
Q&A and comments will be addressed throughout the conference.
This educational event is supported by the following companies by purchasing the stand space and have no interest in the course content.
Boehringer Ingelheim I Dermal I Astra Zeneca I Theramex Ego Pharmaceutical I Mayoly UK I Novo Nordisk